Skip to main content
. 2022 Mar 9;14(6):1404. doi: 10.3390/cancers14061404

Figure 2.

Figure 2

Forest plot of comparison between non-small cell lung cancer patients receiving immune checkpoint inhibitors with concomitant PPIs and/or H2RAs use or not; the outcome (ES) was Hazard Ratio of Overall Survival. Abbreviations: CI: confidence interval; ES: Effect Size (Hazard Ratio); W: Weight.